Do You Actually Have to Take a CogScreen in 2026?

TL;DR: No, not everyone does. Whether you face a CogScreen-AE depends on which pathway you are in, not on your diagnosis alone. ADHD Fast Track skips it; ADHD Standard Track requires it. Antidepressant initial certification requires it; antidepressant renewals have not routinely required it since December 15, 2022. Substance and HIMS cases almost always include it. And one document overrides every general rule below: your FAA Authorization letter. If that letter names CogScreen, you are taking a CogScreen, whatever the policy says in general.

---

The question behind the question

Search any pilot forum for CogScreen and you will find the same post written a hundred different ways. Someone discloses a condition, gets deferred, hears the word "neuropsych," and starts reading. Within an hour they have concluded that a proprietary computer test is standing between them and their career, and that everyone with their diagnosis has to take it.

Often that is not true. A large share of the fear I see is people preparing for an evaluation they will never be assigned, and a smaller but more painful share is people who assumed they were exempt and got surprised.

This post is the map I wish existed. It is organized by pathway, because that is how the FAA actually decides, and it is explicit about what changed and when, because a lot of what circulates in forums describes rules that were replaced years ago.

One boundary before we start. I am an aviation neuropsychology educator. I am not your AME, not a HIMS AME, and not the FAA. What follows is general policy as published in the Guide for Aviation Medical Examiners. Your individual case is governed by your own letter and your own AME.

The master table

Your situation	Pathway	CogScreen-AE required?
ADHD, meets all Fast Track criteria	ADHD Fast Track	No
ADHD, does not meet Fast Track criteria	ADHD Standard Track	Yes, inside a full neuropsych battery
Antidepressant, first time certifying	SSRI Decision Path II (HIMS AME)	Yes
Antidepressant, renewing an existing SI	Recertification / AASI PATH	No, since Dec 15 2022, unless your letter says otherwise
Anxiety or depression, no medication, meets Fast Track	Anxiety/Depression Fast Track	Generally no
Substance dependence or abuse	HIMS	Yes, in nearly all cases
Head injury, TBI, seizure, stroke, other neurologic	Item 46 neurological review	Usually, when the FAA orders a neuropsych evaluation
Airline hiring assessment	Not an FAA process at all	Employer's choice, unrelated to your medical

The rest of this post explains the rows that trip people up.

ADHD: the whole question is which track

This is the single most common source of confusion, and the answer is cleaner than most pilots expect.

Fast Track does not include a CogScreen. If you qualify, you are evaluated by a psychologist or neuropsychologist who conducts an interview and reviews your records, completes the FAA's Fast Track ADHD Summary, and writes a report. There is no CogScreen-AE in that package.

Standard Track does. Standard Track requires a full neuropsychological evaluation, and CogScreen-AE is part of it, alongside a broader battery.

So the real question is never "does ADHD require CogScreen." It is "do I qualify for Fast Track." The FAA's Fast Track criteria are narrow and worth reading closely, because one item catches people who assume they are safe: you are ineligible if you have taken ADHD medication in the past four years, had symptoms in the past four years, or have a history of any other psychiatric condition.

That third clause matters enormously. A pilot can be years past their last dose, completely honest, and still land in Standard Track because a second diagnosis sits in their records. We wrote about what happens when that surfaces late in what a Fast Track reversal letter means.

If you are trying to work out which track applies to you, start with Standard Track vs Fast Track and the ADHD disposition table explained.

Antidepressants: initial and renewal are completely different

Here is where forum advice ages badly, because the rule genuinely changed and a lot of pilots are still repeating the old one.

Initial certification: yes, CogScreen is part of it. A pilot certifying for the first time while taking an FAA conditionally acceptable antidepressant goes through SSRI Decision Path II with a HIMS AME. That package includes a psychiatric evaluation and a neuropsychological evaluation, and the FAA's Specifications for Neuropsychological Evaluations for Treatment with SSRI Medications govern its content. This has not changed.

Renewal: no, not routinely, and not since late 2022. On December 15, 2022, after studying data from 425 pilots in the SSRI program, the FAA determined that the neuropsychologist evaluation and routine CogScreen-AE administration are no longer necessary for renewal of an SSRI special issuance. The change applied to all classes, and to air traffic control specialists as well.

That is the reform pilots often describe as new. It is nearly four years old.

The exception that swallows the rule. The FAA's language is "no longer necessary for RENEWAL of an SSRI special issuance, except when clinically indicated or specified on the Authorization/Special Consideration Letter." A small number of cases still get a follow-up CogScreen, and when they do, it is named in the letter. Read your letter before you conclude anything from this post.

The FAA also said it would regenerate Authorization letters as cases came up for review, removing the CogScreen requirement in most of them. So if you hold an older letter that still names CogScreen, that is worth a conversation with your HIMS AME rather than an assumption in either direction.

If you are on this pathway, our guide to SSRI certification covers the full sequence, and why the stability period exists explains the waiting.

What the July 2026 AASI PATH change did and did not do

The most recent update in this space landed on July 29, 2026, when the FAA added an AME Assisted Special Issuance pathway for anxiety, depression, and related conditions, with a one-page PATH Status Summary.

PATH is a renewal mechanism. If your Authorization letter says you are approved for it, your AME can reissue in the office instead of routing every renewal back to Oklahoma City. Your first Authorization still goes through the FAA, and PATH does not replace the HIMS process for anyone certifying for the first time on an antidepressant.

The PATH documents do not mention CogScreen-AE. It is a renewal pathway change, not a testing requirement change. We covered it in detail in the AASI PATH breakdown.

One connection worth noting anyway: the first question on the PATH Status Summary asks your treating clinician to attest about any deterioration in cognition, judgment, emotional stability, insight, or functioning. Formal testing is not ordered, but cognitive status became a recurring, documented checkpoint.

Anxiety and depression without medication

If you have a history of anxiety or depression, were never on a disqualifying medication, and meet the criteria on the FAA's Anxiety, Depression, and Related Conditions Fast Track decision tool, you are generally not looking at a neuropsychological evaluation.

That tool is a screening checklist the AME completes, and like the ADHD version it is unforgiving about additional diagnoses. Multiple concurrent medications, a history of major depressive disorder or dysthymia, prior suicidal ideation or self harm, involuntary evaluation, or certain treatment modalities all move you off the Fast Track. So does ADHD that does not independently meet ADHD Fast Track requirements.

Substance cases and HIMS

If your pathway runs through HIMS for alcohol or substance dependence, expect CogScreen-AE as part of a full neuropsychological evaluation. This is the use case CogScreen was most clearly built and validated for, and it is the context in which even the test's critics tend to concede it has value.

Neurologic conditions

Head injury, concussion with sequelae, seizure, stroke, and other neurologic events are handled under Item 46, and the FAA commonly orders a neuropsychological evaluation. When it does, CogScreen-AE is typically part of the specified battery.

"Typically" is doing real work in that sentence. These cases are individually specified, and the controlling document is the letter you receive, not a general rule.

The one that is not an FAA requirement at all

A meaningful number of pilots take CogScreen for reasons that have nothing to do with medical certification: airline hiring. Several carriers have used CogScreen as part of candidate assessment, and at least one has collected baseline data on new hires.

If you are sitting a CogScreen for an employer, none of the pathway rules above apply to you. There is no Authorization letter, no FAA review, and no special issuance. It is a hiring assessment, and it is worth being clear with yourself about which of the two situations you are actually in, because pilots occasionally arrive at our door braced for a certification fight when they have a job interview.

Then versus now: what actually changed

Forum threads preserve old rules indefinitely. Here is the short version of what moved.

Change	When	Effect on CogScreen
SSRIs first permitted with special issuance	2010	Established neurocognitive testing "including, but not limited to, CogScreen-AE" for the pathway
ADHD Fast Track / Standard Track split formalized	2024	Created a documented route that skips CogScreen entirely
SSRI renewal testing dropped	Dec 15, 2022	Routine CogScreen and neuropsych no longer required at renewal, with exceptions
Antidepressant stability period cut	2026	Six months on a stable dose reduced to three. Did not change whether CogScreen applies
Therapy and counseling guidance added	May 27, 2026	Item 47 guidance encouraging care. No testing change
AASI PATH for anxiety and depression	July 29, 2026	Renewal handled at AME level. No mention of CogScreen

What has not changed: no pilot flies on ADHD medication, initial antidepressant certification still requires the full package, and complex neurologic and substance cases still get formal neuropsychological evaluation.

Three pilots, three answers

To make this concrete, and these are illustrations rather than real people:

A student pilot with a childhood ADHD diagnosis, off medication since age 14, no other diagnoses. Likely Fast Track. Likely no CogScreen. The work is documentation, not test preparation.

A regional first officer starting sertraline for the first time. Decision Path II with a HIMS AME. CogScreen is part of the initial package. Preparation is worth the time.

A corporate captain on a stable antidepressant SI for six years, renewing. Probably no CogScreen, because of the December 2022 change. But the answer is printed on the Authorization letter, not decided by this article.

What to do next

1. Find your letter. If you hold an Authorization or Special Consideration letter, it is the controlling document. General policy loses to your letter every time.
2. Identify your pathway, not your diagnosis. "I have ADHD" does not determine anything. "I qualify for Fast Track" does.
3. Ask your AME one specific question: "Based on my history, which pathway are you submitting me under, and does that pathway include a neuropsychological evaluation?" That question gets a far more useful answer than asking whether you need a CogScreen.
4. If you are already deferred, request your records. FAA Form 8065-2 gets you your complete medical file. See our guide to deferrals and records requests.
5. If CogScreen is in your path, learn the format early. Not to inflate a score. To make sure the score reflects your cognition rather than your first encounter with an unfamiliar interface. Start with what the 13 subtests measure and what test day looks like.

Sources

• FAA Guide for Aviation Medical Examiners, Item 47: Use of Antidepressant Medications
• FAA, SSRI Recertification: Neuropsychological Report Changes and FAQs (policy change 12/15/2022)
• FAA, HIMS AME Checklist: SSRI Recertification/Follow-Up Clearance
• FAA, Fast Track: FAA ADHD Evaluation General Information for Pilots and ATCS
• FAA, ADHD Disposition Table and ADHD Pathway Chart
• FAA, Anxiety, Depression, and Related Conditions Fast Track Pathway Decision Tool
• FAA, AASI for Anxiety, Depression, and Related Conditions PATH, and PATH Status Summary (July 29, 2026)
• FAA, Specifications for Neuropsychological Evaluations for Treatment with SSRI Medications

---

If your pathway does include cognitive testing, the format is the part you can do something about. See how CogScreen-AE familiarization works, or try three questions per module free to see the task formats before deciding whether structured preparation makes sense for your situation.